S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Safest Option in Trades! (Ad)pixel
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
The Safest Option in Trades! (Ad)pixel
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
The Safest Option in Trades! (Ad)pixel
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Safest Option in Trades! (Ad)pixel
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
The Safest Option in Trades! (Ad)pixel
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
The Safest Option in Trades! (Ad)pixel
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Safest Option in Trades! (Ad)pixel
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
The Safest Option in Trades! (Ad)pixel
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
The Safest Option in Trades! (Ad)pixel
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
The Safest Option in Trades! (Ad)pixel
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
The Safest Option in Trades! (Ad)pixel
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
The Safest Option in Trades! (Ad)pixel
Why Investors Are Eating Up Restaurant Brands International
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
NASDAQ:AXON

Axon Enterprise - AXON Stock Forecast, Price & News

$181.26
-2.68 (-1.46%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$181.08
$185.21
50-Day Range
$119.45
$192.14
52-Week Range
$82.49
$193.85
Volume
422,505 shs
Average Volume
632,427 shs
Market Capitalization
$12.90 billion
P/E Ratio
125.01
Dividend Yield
N/A
Price Target
$168.25

Axon Enterprise MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
7.2% Downside
$168.25 Price Target
Short Interest
Bearish
3.22% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of Axon Enterprise in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$1.40 M Sold Last Quarter
Proj. Earnings Growth
83.33%
From $0.54 to $0.99 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Industrial Products Sector

158th out of 183 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

5th out of 5 stocks

AXON stock logo

About Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

AXON Stock News Headlines

Axon: Supports Law Enforcement
Why Axon Continues to Be a Top Stock
Axon Q3 Results: Simply Stunning From This Hidden Gem
4 Analysts Have This to Say About Axon Enterprise
Axon stock surges after company reports Q3 revenue gains
No Guardrails for Regulators
Axon: A Shockingly Good Business With A Twist
See More Headlines
Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

AXON Company Calendar

Last Earnings
11/15/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
2,992
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$168.25
High Stock Price Forecast
$200.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
-7.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-60,020,000.00
Pretax Margin
11.63%

Debt

Sales & Book Value

Annual Sales
$863.38 million
Book Value
$17.30 per share

Miscellaneous

Free Float
66,255,000
Market Cap
$12.90 billion
Optionable
Optionable
Beta
0.70

Key Executives

  • Mr. Patrick W. SmithMr. Patrick W. Smith (Age 51)
    Co-Founder, CEO & Director
    Comp: $33.12k
  • Mr. Luke S. LarsonMr. Luke S. Larson (Age 41)
    Pres (Leave of Absence)
    Comp: $828.01k
  • Mr. Joshua M. IsnerMr. Joshua M. Isner (Age 36)
    Chief Operating Officer
    Comp: $2.48M
  • Mr. Jeffrey C. KuninsMr. Jeffrey C. Kunins (Age 47)
    Chief Product Officer & Exec. VP of Software
    Comp: $753.02k
  • Ms. Brittany Bagley (Age 39)
    Chief Financial Officer & Chief Bus. Officer
  • Mr. Jim Zito (Age 41)
    Sr. VP of Accounting & Controller
  • Mr. Jenner Holden
    Chief Information Security Officer
  • Mr. Isaiah Fields
    Corp. Sec. & Chief Legal Officer
  • Ms. Andrea Susan James
    Chief Communications Officer
  • Ms. Elizabeth Hart
    Sr. VP of People Operations













AXON Stock - Frequently Asked Questions

Should I buy or sell Axon Enterprise stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AXON shares.
View AXON analyst ratings
or view top-rated stocks.

What is Axon Enterprise's stock price forecast for 2023?

7 equities research analysts have issued 12 month target prices for Axon Enterprise's shares. Their AXON share price forecasts range from $130.00 to $200.00. On average, they predict the company's share price to reach $168.25 in the next twelve months. This suggests that the stock has a possible downside of 7.2%.
View analysts price targets for AXON
or view top-rated stocks among Wall Street analysts.

How have AXON shares performed in 2022?

Axon Enterprise's stock was trading at $157.00 at the beginning of 2022. Since then, AXON shares have increased by 15.5% and is now trading at $181.26.
View the best growth stocks for 2022 here
.

Are investors shorting Axon Enterprise?

Axon Enterprise saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 2,290,000 shares, an increase of 23.8% from the October 31st total of 1,850,000 shares. Based on an average trading volume of 485,900 shares, the days-to-cover ratio is currently 4.7 days.
View Axon Enterprise's Short Interest
.

When is Axon Enterprise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our AXON earnings forecast
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) released its quarterly earnings results on Monday, November, 15th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.91. The biotechnology company earned $231.99 million during the quarter, compared to analyst estimates of $201.11 million. Axon Enterprise had a trailing twelve-month return on equity of 9.88% and a net margin of 9.75%. The business's revenue was up 39.4% compared to the same quarter last year. During the same period last year, the business posted ($0.01) earnings per share.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.15 billion-$1.16 billion, compared to the consensus revenue estimate of $1.11 billion.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.28%), Vanguard Group Inc. (8.80%), Baillie Gifford & Co. (3.72%), State Street Corp (3.05%), Alliancebernstein L.P. (2.40%) and Conestoga Capital Advisors LLC (1.38%). Insiders that own company stock include Adriane M Brown, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Mark W Kroll, Matthew R Mcbrady, Matthew R Mcbrady and Patrick W Smith.
View institutional ownership trends
.

How do I buy shares of Axon Enterprise?

Shares of AXON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $181.26.

How much money does Axon Enterprise make?

Axon Enterprise (NASDAQ:AXON) has a market capitalization of $12.90 billion and generates $863.38 million in revenue each year. The biotechnology company earns $-60,020,000.00 in net income (profit) each year or $1.45 on an earnings per share basis.

How many employees does Axon Enterprise have?

The company employs 2,992 workers across the globe.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The official website for the company is www.axovant.com. The biotechnology company can be reached via phone at (480) 991-0797, via email at ir@axon.com, or via fax at 480-991-0791.

This page (NASDAQ:AXON) was last updated on 11/30/2022 by MarketBeat.com Staff